123 related articles for article (PubMed ID: 9634925)
21. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Ariga H; Edwards J; Sullivan DA
Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes.
Peck AB; Saylor BT; Nguyen L; Sharma A; She JX; Nguyen CQ; McIndoe RA
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5647-55. PubMed ID: 21666236
[TBL] [Abstract][Full Text] [Related]
23. Lacrimal gland autoimmunity in New Zealand mice.
Tabbara KF; Ohashi Y
Int Ophthalmol Clin; 1985; 25(2):153-63. PubMed ID: 4008179
[TBL] [Abstract][Full Text] [Related]
24. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome.
Saito I; Terauchi K; Shimuta M; Nishiimura S; Yoshino K; Takeuchi T; Tsubota K; Miyasaka N
J Clin Lab Anal; 1993; 7(3):180-7. PubMed ID: 8509947
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's syndrome: an old tale with a new twist.
Lee BH; Tudares MA; Nguyen CQ
Arch Immunol Ther Exp (Warsz); 2009; 57(1):57-66. PubMed ID: 19219532
[TBL] [Abstract][Full Text] [Related]
26. Cytokines may prove useful in the treatment of Sjögrens syndrome (SS) dry eye.
Talal N; Nakabayashi T; Letterio JJ; Kong L; Geiser AG; Dang H
Adv Exp Med Biol; 1998; 438():953-8. PubMed ID: 9634993
[No Abstract] [Full Text] [Related]
27. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.
Arakaki R; Eguchi H; Yamada A; Kudo Y; Iwasa A; Enkhmaa T; Hotta F; Mitamura-Aizawa S; Mitamura Y; Hayashi Y; Ishimaru N
PLoS One; 2014; 9(5):e98390. PubMed ID: 24866156
[TBL] [Abstract][Full Text] [Related]
28. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model.
Tsubota K; Saito I; Ishimaru N; Hayashi Y
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1551-9. PubMed ID: 9699544
[TBL] [Abstract][Full Text] [Related]
29. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
30. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren's syndrome.
Ohyama Y; Carroll VA; Deshmukh U; Gaskin F; Brown MG; Fu SM
J Immunol; 2006 Nov; 177(10):7391-7. PubMed ID: 17082658
[TBL] [Abstract][Full Text] [Related]
31. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
32. Murine models of Sjögren's syndrome.
Jabs DA; Prendergast RA
Adv Exp Med Biol; 1994; 350():623-30. PubMed ID: 8030545
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
Ono M; Rocha FJ; Sullivan DA
Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
[TBL] [Abstract][Full Text] [Related]
34. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549
[TBL] [Abstract][Full Text] [Related]
35. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.
Hayakawa I; Tedder TF; Zhuang Y
Immunology; 2007 Sep; 122(1):73-9. PubMed ID: 17472721
[TBL] [Abstract][Full Text] [Related]
36. Gender- and androgen-related impact on the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary glands of mouse models of Sjögren's syndrome.
Toda I; Wickham LA; Rocha EM; da Silveira LA; Sullivan DA
Adv Exp Med Biol; 1998; 438():447-52. PubMed ID: 9634920
[No Abstract] [Full Text] [Related]
37. Immune Response Targeting Sjögren's Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice.
Trzeciak M; Bagavant H; Papinska J; Deshmukh US
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261673
[TBL] [Abstract][Full Text] [Related]
38. Local suppression of IL-21 in submandibular glands retards the development of Sjögren's syndrome in non-obese diabetic mice.
Liu H; Liu G; Gong L; Zhang Y; Jiang G
J Oral Pathol Med; 2012 Nov; 41(10):728-35. PubMed ID: 22643047
[TBL] [Abstract][Full Text] [Related]
39. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
